3-17-15


PROPOPSED INVESTMENT TERM SHEET


 


between


 


EVENT CARDIO GROUP, INC.


 


and


 


(R.J. Capital Management, Ltd.)








 


This term sheet (“Term Sheet”)
between Event Cardio Group Inc. (“ECGI”), a Nevada Corporation with its principle place of business at 2798 Thamesgate
Dr., Mississauga, Ontario, Canada L4T 4E8, and (R. J. Capital Management, Ltd.), a Hong Kong corporation with an address at ____________,
Hong Kong, sets forth the understanding of the parties regarding R. J. Capital Management, Ltd.’s proposed purchase of securities
issued by ECGI. Immediately following the execution of this Term Sheet, the parties shall undertake to formalize this Term Sheet
in a Securities Purchase Agreement.


 


This term sheet is non-binding and subject
to the parties entering into formal agreements setting forth their respective rights and obligations. Such agreements shall contain
customary representations, warranties and indemnifications.


 


Confidentiality


 


The existence of this Term Sheet, all of its
individual terms and conditions and the purchase or issuance contemplated hereby are of a confidential nature and shall not be
disclosed by ECGI to anyone, except its management, board members, advisors, legal counsel and auditors, without the written consent
of R. J. Capital Management, Ltd .


 


 





	Preliminary Terms

         

	Issuer:	Event Cardio Group Inc. (OTC: ECGI)

         

	Investor:	R. J. Capital Management, Ltd. or
        its affiliate

         

	Securities Offered:	Common Stock

         

	Transaction Amount:	US$4 million

         

	Valuation:	Post-money US$20 million on a fully
        diluted basis. There are currently 92 million shares outstanding and 5,000,000 shares issuable upon exercise of outstanding
        options, warrants and convertible debt. Investor will own 24,250,000 shares representing approximately 20% of ECGI’s
        outstanding common stock. If shares or options or other rights exercisable for or convertible into shares of ECGI are
        issued prior to closing, the number of shares to be issued to Investor will be adjusted so as to equal 20% of ECGI’s
        outstanding common stock post-deal.

         

	Structure:	Investor invests $4 million into the public company at closing.

                                                           

	




    	 	 	 



    	 



    
	

        Joint Venture:

         

         

         

         

         
	

        ECGI and the Investor will form
a Joint Venture which will have exclusive distribution and manufacture rights to the BreastCare DTSTM in China. The
initial capitalization of the JV will be $5 million of which $4 million will be contributed by the Investor and $1 million will
be contributed by ECGI. Initially, the ownership of the JV will be Investor – 80%; ECGI – 20%. Investor will have
the right to invest an additional $5 million prior to dilution of ECGI’s 20%..

         

	Use of Proceeds:	ECGI will use the proceeds to commercialize
        the BreastCare DTSTM device in North America and the People’s Republic of China

         

	Governing Law:	New York Law

         

	Others:	The parties acjnowledge that the execution         of the Securities
    Purchase Agreement is subject to R. J. Capital Management, Ltd’s due diligence to its satisfaction.



                                                           

	Timing;
	


        This offer will remain open
only until 5 PM, March 15, 2015 (Hong Kong Time), and may not be accepted after that date. If accepted, the transaction contemplated
hereby must closing no later than April 1, 2015, subject to the right of R. J. Capital Management, Ltd to extend the closing for
up to 15 days by the payment of $1,000,000 of the $4,000,000 subscription amount. Upon payment of such $1,000,000, ECGI shall
issue to the investor shares representing 5% of the then outstanding shares of ECGI on a fully diluted basis.



 


This term sheet does not constitute or evidence a binding offer
or agreement, nor shall it or any discussions or course of conduct impose any obligation or liability on any of the Parties until
copies have been executed and delivered by both parties. A binding agreement with respect to the proposed transaction will arise
only after the Investor has completed its due diligence (with results satisfactory to them) and mutually satisfactory definitive
agreements have been negotiated and executed (it being understood that the Parties shall not have any obligation or commitment
to enter into such definitive agreements).


 


IN WITNESS WHEREOF, the parties hereto have executed this agreement
as of the date first stated above.


 


 


	Event Cardio Group Inc.

         

         

         

        By: ___/s/ John Bentivoglio_______________

        Name: John Bentivoglio

        Title: President

         

        Agreed and accepted as of the 17th March, 2015
	R. J. Capital Management, Ltd 

         

         

         

        By: ___/s/ Songge Teng_______________

        Name: Songge Teng

        Title: Director

         

        Agreed and accepted as of 17th March 2015